Cancer News and Research

Latest Cancer News and Research

BRAF gene mutations predict sensitivity to a new class of drug

A team of researchers led by scientists at Memorial Sloan-Kettering Cancer Center have discovered that a new class of drugs -- now in early stage clinical trials -- work best in patients with mutations in the BRAF gene.

7 Nov 2005

Ultrasound to treat cancer

For the first time, ultrasound is being used in animal models – to treat cancer by disrupting tumor blood vessels.

7 Nov 2005

Unethical for doctors to withhold information from patients about new drugs

It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week's British Medical Journal.

7 Nov 2005

New understanding of sphingosine kinases called SphK1 and SphK2

Virginia Commonwealth University Massey Cancer Center researchers have found that two enzymes that catalyze the same reaction and produce the same product have opposite effects on cell growth and death.

7 Nov 2005

Only 10 percent of doctors have ever heard of fibrodysplasia ossificans progressiva

A new research study shows how common a medical misdiagnosis can be and how severely it can exacerbate a disease.

7 Nov 2005

Smokeless tobacco products are not necessarily a safe alternative to smoking

According to the U.S. Centers for Disease Control and Prevention, nearly one-fourth of Americans are smokers. That's more than 60 million people who are at increased for lung cancer, the leading cause of cancer-related deaths nationwide.

3 Nov 2005

Expert highlights public health problem posed by colorectal cancer

Colorectal cancer is a significant public health problem for which differing treatment regimes hold different benefits in associated efficacy, safety and tolerability, according to study findings showcased at the 13th European Cancer Conference (ECCO).

3 Nov 2005

Largest study to date on risk factors associated with primary biliary cirrhosis

A case-control study of more than 2000 people has identified a number of factors that may induce primary biliary cirrhosis (PBC) in genetically susceptible individuals. These include a history of urinary tract infections, hormone replacement therapy, tobacco use, and nail polish use.

3 Nov 2005

Clinicans warned about randomized clinical trials

A review article in the November 2 issue of JAMA: The Journal of the American Medical Association, suggests clinicians ought to view with skepticism the results of randomized clinical trials stopped early because of apparent benefit.

3 Nov 2005

Ospemifine may also help to prevent breast cancer

A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.

3 Nov 2005

Issues faced by cancer patients - assessement - impact - implications

New study findings showcased at the 13th European Cancer Conference (ECCO) have shed further light on the manifold factors which must be considered when managing patients with cancer. Studies from around Europe looked at a number of the issues faced by cancer patients and assessed their impact and associated implications.

3 Nov 2005

Testicular cancer survivors can still have children

The overall rate of fatherhood after treatment for testicular cancer is high, but the ability to conceive and the time to conception are influenced by the type and intensity of treatment, according to a new study in the November 2 issue of the Journal of the National Cancer Institute.

3 Nov 2005

Vaccine that targets nicotine rather than the brain's reaction to it

Since smoking became popular in America in the 1930s, lung cancer rates have continued to climb. Today, it is still the leading cause of cancer-related deaths, with totals more than the other five leading cancers combined.

3 Nov 2005

Capecitabine and Gemcitabine help battle pancreatic cancer

The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.

3 Nov 2005

Women show a better response to lung cancer therapy, resulting in better survival rates

However, in untreated patients, women also had a 21 percent decreased risk of death as compared with men, leading researchers to believe lung cancer in women has a different biologic behavior and natural history than in men.

3 Nov 2005

Rapid screen-and-treat methods significantly reduce cervical cancer precursor lesions

A new study led by Columbia University Medical Center researchers demonstrates the safety and efficacy of two low-tech diagnostic tools to significantly reduce the prevalence of cervical cancer precursor lesions.

3 Nov 2005

New therapies for prostate cancer

A Dutch study suggested treating prostate cancer patients with higher doses of radiotherapy significantly improved patient outcome and treatment over a five-year period.

3 Nov 2005

Substance found in evening primrose oil inhibits breast cancer gene

Gamma-linolenic acid (GLA), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 percent of all breast cancers, Northwestern University researchers report.

3 Nov 2005

New targeted cancer drug delivery system

Prostate, breast and other cancer patients may be offered a new, stauncher targeted drug delivery system to treat their diseases in the next decade.

3 Nov 2005

DN-101 may protect against major side effects of chemotherapy

Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study.

3 Nov 2005